The strategic research program in Stem Cell Research and Regenerative Medicine at Karolinska Institutet (StratRegen) supports research that advances our understanding of stem cell biology and approaches to bring regenerative medicine to the clinic, for future treatment of diseases for which there currently are no therapies.
Research in StratRegen spans a broad spectrum of projects, ranging from understanding fundamental aspects of stem cell differentiation to novel strategies for bone marrow transfer and biosynthetic organ generation. StratRegen also supports a number of key research infrastructures at Karolinska Institutet. The programme is supported by the government through the strategic initiatives.
Eva Hellström Lindberg
The Wallenberg Institute for Regenerative Medicine (WIRM) is a Research Institute financed by a grant from Knut och Alice Wallenbergs Stiftelse. The aim of WIRM is to advance research on the blood system at Karolinska Institutet, both during normal hematopoietic development and in disease.
This is accomplished by recruitment of leading international expertise, both at the senior level and at the level of new junior group leaders. WIRM also builds new important research infrastructure for stem cell research and regenerative medicine, ranging from a state-of-the-art FACS facility to supporting research infrastructures for cellular reprogramming/iPS, GMP production of clinical grade cells, transgenic mouse technology, zebrafish and live cell imaging.